Table 1 Clinical data of diabetic subjects with and without TNs
Characteristics | Total | TNs | Non-TNs | z/t//χ2 values | P values |
|---|---|---|---|---|---|
N = 370 | N = 229 | N = 141 | |||
Age(y) | 62.0(21.0) | 65.0(16.0) | 52.0(23.0) | -6.353 | < 0.001 |
Gender, male (%) | 210(56.8) | 105(45.9) | 105(74.5) | 29.117 | < 0.001 |
Duration of diabetes(y) | 10.0(15.0) | 13.0(14.0) | 7.0(14.0) | -3.887 | < 0.001 |
DN, n (%) | 167(45.1) | 116(50.7%) | 51(36.2%) | 7.394 | 0.007 |
SII | 400.0(297.3) | 443.2(338.3) | 335.1(234.4) | -4.677 | < 0.001 |
AISI | 151.1(141.9) | 173.2(180.7) | 134.9(86.7) | -4.314 | < 0.001 |
TT3(ng/ml) | 0.8(0.3) | 0.8(0.2) | 0.9(0.3) | -2.297 | 0.017 |
FT3 (pg/mL) | 3.0(1.5) | 3.0(0.6) | 3.1(0.6) | -2.720 | 0.007 |
TSH (µIU/ml) | 1.8(1.4) | 1.8(1.5) | 1.8(0.9) | -0.766 | 0.444 |
TT4 (µg/dL) | 8.9 ± 1.7 | 9.0 ± 1.7 | 8.6 ± 1.7 | 2.253 | 0.025 |
FT4 (ng/dL) | 0.9(0.2) | 0.9(0.2) | 0.9(0.2) | -0.809 | 0.419 |
TPOAB (IU/ml) | 0.5(0.8) | 0.5(0.9) | 0.5(0.8) | -0.731 | 0.465 |
TGAB (IU/ml) | 0.0(0.1) | 0.0(0.2) | 0.0(0.1) | -0.415 | 0.678 |
Scr (µmol/L) | 66.0(29.0) | 65.0(31.0) | 66.0(26.0) | -0.090 | 0.928 |
eGFR(ml/min) | 94.4(27.6) | 91.3(30.8) | 104.5(25.2) | -4.909 | < 0.001 |
BUN (mmol/L) | 5.4(2.6) | 5.6(3.0) | 5.1(2.7) | -2.194 | 0.028 |
UA (µmol/L) | 321.5(149.0) | 325.0(154.0) | 312.0(130.0) | -1.360 | 0.174 |
FPG (mmol/L) | 8.0(4.2) | 8.2(4.5) | 7.7(3.8) | -1.564 | 0.118 |
HbA1c (%) | 8.9(3.2) | 8.7(3.3) | 9.3(3.1) | -1.568 | 0.117 |
HOMA-IR | 4.0(4.5) | 4.2(5.0) | 3.6(3.8) | -1.768 | 0.077 |
INS (mIU/L) | 11.4(10.3) | 11.6(10.8) | 10.7(10.1) | -1.286 | 0.198 |
C-P(ng/ml) | 2.0(1.7) | 2.0(1.7) | 2.0(1.8) | -0.259 | 0.795 |
TG (mmol/L) | 1.6(1.2) | 1.7(1.3) | 1.6(1.0) | -0.996 | 0.319 |
CHO (mmol/L) | 4.3(1.5) | 4.4(1.5) | 4.3(1.5) | -0.882 | 0.378 |
HDL (mmol/L) | 1.0(0.4) | 1.0(0.4) | 0.9(0.3) | -1.551 | 0.121 |
LDL (mmol/L) | 2.6 ± 0.9 | 2.6 ± 0.9 | 2.6 ± 0.9 | -0.039 | 0.969 |